Intervention Strategies: Bonus Episode - Busting myths and restoring trust in vaccines

What are the causes for the steady and at times dramatic decline in vaccine confidence seen since the mid-90’s across certain age-groups and communities? Why has the public discourse changed? And how did the persistent and lingering myth linking vaccines to autism take hold? In this insightful episode, a panel of accomplished experts tackle these pressing questions, offering astute explanations and powerful counter-strategies to combat misinformation and restore trust in vaccines. Join Ted van Essen, TV doctor, GP and ESWI Board Member with many years of experience in public health work as chair of the Dutch Immunisation Foundation; Heidi Larson, Founder and Director of the Vaccine Confidence Project, author of “How vaccine rumours start”, and named one of the 100 most influential women in the world by the BBC in 2021; and, Sue Saville, former Medical Correspondent at Britain’s ITV News, now an independent health communications specialist bringing a wealth of experience as a speaker, writer, trainer and more. 

In this episode, our distinguished experts and coalition partners unwrap and define key intervention strategies for acute respiratory viruses. Building on insights from previous episodes they offer fresh perspectives and bring to light the complexity of prevention, diagnostics and therapy.Our discussion features ESWI Chair Colin Russell, Professor of Applied Evolutionary Biology, at the University of Amsterdam alongside contributions from Catherine Weil-Olivier, Honorary Professor of Paediatrics at Paris-Cité University, France, and Board Member of the Coalition for Life Course Immunisation and Barbara Rath, Pediatrician and Infectious disease Specialist and Co-founder and Chair at Vaccine Safety Initiative.Why is seeking early testing so fundamental? How can translating discourse improve intervention efforts? What does understanding the patient journey entail? And finally, could an annual virus weather report become a reality? Do not miss this episode, where science meets strategy in the fight against respiratory viruses.This episode was made possible from the kind support of Moderna, Viatris and AstraZeneca.

Learn about the fascinating story behind the intriguing Human metapneumovirus (hMPV) and how it was first discovered. Why were parents once asked about contact with birds? How can the recent outbreak in China make a difference? Join an insightful conversation with distinguished guests and leading experts Ab Osterhaus, Member of the ESWI board and Director of the Center of Infection Medicine and Zoonosis Research and Guest-Professor at the University of Veterinary Medicine Hannover, Germany, who first identified the virus together with Bernadette van den Hoogen, Associate Professor at Erasmus Medical Center in Rotterdam, and Ann Falsey, Professor of Medicine, Infectious Diseases, and co-director of the Vaccine Treatment and Evaluation Unit at the University of Rochester School of Medicine.They tease out the subtle differences between HMPV, flu, and RSV, discuss the burden of disease, the role of diagnostics and the importance of fundamental research. Plus, why does public awareness matter and could a name change be on the horizon?This episode was made possible from the kind support of AstraZeneca.

A riveting episode from three unique perspectives on intervention strategies and the ongoing challenges posed by Sars-Cov-2, the virus behind one of the deadliest pandemics in recent history. Featuring a fundamental researcher, a virologist, and a clinician, our speakers engage in a captivating talk on Covid-19. Is it endemic now? What’s new on the diagnostics and therapeutic front? How many annual vaccines can the public reasonably deal with?  Join us for this fascinating conversation that bridges research, clinical practice, and public health to address the evolving landscape of Covid-19 and other respiratory viruses.This episode is supported by Moderna.

Tremendously exciting times and possibly underestimating the enormity of its impact. These are some of the comments we hear when experts share their insights on the recently available RSV vaccines. We are told about the disastrous first attempts of a vaccine 60 years ago and some of the road bumps leading to today’s success. In this episode, join us as we delve into the history, challenges, and triumphs of RSV vaccine development. Our renowned speakers give detailed accounts of the new RSV vaccines, including target population, critical gaps in vaccination for vulnerable groups, national immunisation programmes and the urgency of expanding access to resource poor settings.RSV and the bumpy road towards a vaccine is supported by Moderna.

Flu Vaccines: Advancements, Challenges, and Global Impact – Expert Insights on Vaccine Platforms and Immune ResponsesIn this phenomenal episode, three leading experts in the field of vaccinology and immunology dive into the science behind various vaccine platforms and immune responses. Tune in as they explore the evolution of vaccines, from early, early vaccine platforms to cutting-edge technologies, and discuss the advantages and disadvantages of each approach.  In a dynamic, educational conversation, we hear about the quest for the holy grail, the crucial role of CD8 T-cells, and the global challenges of vaccine accessibility and hesitancy.Join Professor Ab Osterhaus, ESWI Executive Committee Member and Director of the Center of Infection Medicine and Zoonosis Research at the University of Veterinary Medicine Hannover, Germany; ESWI Board Member Florian Krammer, Professor of Vaccinology at the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York, and Professor for Infection Biology at the Medical University of Vienna; and ESWI Associate Member Carolien van de Sandt, Senior Research Fellow, Department of Microbiology and Immunology at the Peter Doherty Institute, Australia in this thought-provoking discussion on the future of vaccines and global health.With the support of Moderna and Viatris.

Welcome to ESWI Airborne, the podcast of the European Scientific Working Group on Influenza. In this  episode, we explore essential skills and career prospects for early career scientists as part of our three-part series on life as a scientist.Joining me are three remarkable guests:Meral Akcay, a global influenza expert and former ESWI board member, who discusses her transition from academia to the pharmaceutical industry and the key skills that have propelled her career.Lucy Mosscrop, a passionate science enthusiast and PhD candidate at Imperial College London, focusing on RSV research. Lucy shares her aspirations and the valuable skills she has found beneficial throughout her journey.Marco Goeijenbier, an ESWI board member and clinician with a dynamic career in research, who emphasizes the importance of curiosity and mentorship in navigating the competitive landscape of scientific careers.Together, we’ll delve into their unique journeys, the challenges they face, and the advice they offer to those just starting out in science. Whether you're a budding scientist or simply curious about the field, this episode provides a wealth of knowledge to guide you on your professional path.

Join in on this enthusiastic and insightful conversation between Nathan Brendish, associated with the University of Southampton in the United Kingdom, and Irene Gonzalez and Florian Krammer from the Icahn School of Medicine at Mount Sinai in the United States of America. Explore the joys and sorrows of embarking on a scientific career in this episode as we delve into the nomadic life of scientists as they explore the world in search of new and existing data in the field of respiratory viruses.

Do not miss the opportunity to listen to this enthusiastic and insightful conversation between Debby van Riel, Associate Professor, Department of Viroscience, Erasmus MC, The Netherlands, Carolien van de Sandt, Senior Research Fellow, Department of Microbiology and Immunology at the Peter Doherty Institute, Australia, and Jenna Guthmiller Assistant Professor at the Department of Immunology and Microbiology from University of Colorado Anschutz Medical Campus, US,  examine the joys and sprrows of embarking on a scientific career. How does the real-life experience of working as a scientist compare to your initialExpectations? What are the typical challenges encountered by early career scientists? What advice would you give to someone considering a career in science? Looking ahead, what are the big questions that you want to address? What advice would you give to someone considering a career in science?

How has the world of travel medicine evolved? What multiple roles do vaccinations have? What impact did the COVID-19 pandemic have on travel behaviour? Why is it so important to keep up to date on the current epidemiological situation? Delve into the fascinating world of travel medicine, listening to George Kassianos, GP, ESWI Board Member and President of the British Global and Travel Health Association, Dipti Patel, Specialist in occupational medicine and travel medicine physician and Director at the National Travel Health Network and Centre and Robert Steffen, Emeritus Professor at the Epidemiology, Biostatistics and Prevention Institute, University of Zurich, also known as the father of travel medicine. We learn which group of travellers are - surprisingly - of most concern for health care specialists, and what some of the geographical hotspots are. We will also get a snapshot of the recommended updated Covid-19 vaccine, and much more.